Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Food

Novartis Consumer Health: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Agency Publication Date: September 19, 2013
Share:
Sign in to monitor this recall

Affected Products

Product: Benefiber, Fiber plus Calcium Supplement, Wild Berry Chewables 90ct, sugar free, chewable tablets bottle. Novartis Consumer Health, Inc, Parsippany, NJ.

Lot Number and Expiration date 10118852 , 6/30/2013; 10123090, 8/31/2013; 10127095, 10/31/2014.

Lot Numbers:
Number
Product: Benefiber, Fiber Supplement, Orange Creme Chewables, Sugar Free, 36ct and 100ct chewable tablet bottles. Novartis Consumer Health, Inc, Parsippany, NJ.

Lot Number and Expiration date (36ct bottle): 10117915, 5/31/2014; 10118335, 7/31/2014; 10120615, 9/30/2014; 10110703A 3/31/2014. (100ct bottle): 10110706, 2/28/2014; 10112140, 2/28/2014; 10113261, 5/31/2014; 10116530, 5/31/2014; 10120059, 7/31/2014; 10120616, 8/31/2014; 10125996, 9/30/2014 and 10109551, 3/31/2015.

Lot Numbers:
Number
Product: Benefiber, Fiber Supplement, 72ct and 114 caplet bottles. Novartis Consumer Health, Inc, Parsippany, NJ.

Lot Number and Expiration date 72 ct bottle: 10100086, 9/30/2013 114 ct bottle: 10093114, 6/30/2013; 10095522, 7/31/2013; 10095531, 7/31/2013; 10097337, 8/31/2013; 10099444, 9/30/2013; 10099445, 9/30/2013; 10101260, 10/31/2013; 10102755, 11/30/2013; 10104634, 12/31/2013; 10104635, 1/31/2014; 10108857, 1/31/2014; 10112134, 2/28/2014; 10112135, 4/30/2014; 10113255, 5/31/2014; 10116304, 5/31/2014; 10118831, 6/30/2014; 10119626, 6/30/2014; 10120461, 7/31/2014; 10120462, 7/31/2014; 10124311, 9/30/2014; 10128842, 10/31/2014.

Lot Numbers:
Number
Product: Benefiber, Fiber Supplement, Assorted Fruit, Sugar Free, 100ct chewable tablets. Novartis Consumer Health, Inc, Parsippany, NJ.

Lot Number and Expiration date 10110708, 5/12/2011; 10110806, 5/10/2011; 10111858, 6/8/2011; 10112132, 6/17/2011; 10113256, 7/25/2011; 10116303, 9/9/2011; 10116444, 9/8/2011; 10118336, 10/6/2011; 10118337, 10/6/2011; 10119374, 10/31/2011; 10119376, 10/4/2011; 10120002, 12/6/2011; 10120003, 11/1/2011; 10123092, 12/6/2011; 10123093, 11/18/2011; 10125929, 12/21/2011; 10125995, 12/21/2011;

Lot Numbers:
Number
Product: Benefibre, Orange Creme Chewables, 36ct and 100ct chewable tablet bottles. Foreign labeling: Novartis Consumer Health Canada Inc, Mississauga, ON.

Lot Number and Expiration date 36ct bottle: 10101294, 12/31/2013; 10114155, 4/30/2014 100ct bottle: 10097346,8/31/2013;10104669,12/31/2013;10117018,1/31/2014;10117019, 4/30/2014;10120625,8/31/2014.

Lot Numbers:
Number

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 66013
Status: Resolved
Manufacturer: Novartis Consumer Health
Manufactured In: United States
Units Affected: 5 products (26,604 units; 165,480 units; 504,456 units; 419,040 units; 70,380 units)

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.